Quest Diagnostics target price raised to $265 from $254
DGX•Leerink Partners raised its target price for Quest Diagnostics to $265 from $254.
Related News
Lightspeed to host fiscal Q2 2027 results conference call and webcast
LSPD•
Ballard up on 4.8 MW order to power hydrogen trains in Romania
BLDP•
Shaky $4 bln neocloud IPO reportedly pricks AI bubble
NVDA•
USTR Greer says US 'holding fast' on trade stance with Canada
SPY•
Iran to respond to US views on its proposal within a few days, foreign minister says
USO•